Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Heitjan

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 25, 2000
Gemcitabine for relapsed or resistant lymphomaD G Savage, S A Rule, M Tighe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Phase I trial of docetaxel with estramustine in androgen-independent prostate cancerD P Petrylak, R B Macarthur, J O'Connor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 1998
Phase I trial of sequential high-dose chemotherapy with escalating dose paclitaxel, melphalan, and cyclophosphamide, thiotepa, and carboplatin with peripheral blood progenitor support in women with responding metastatic breast cancerL T Vahdat, K Papadopoulos, C Balmaceda, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 27, 2016
Efficacy of the nanoparticle-drug conjugate CRLX101 in combination with bevacizumab in metastatic renal cell carcinoma: results of an investigator-initiated phase I-IIa clinical trialS M Keefe, J Hoffman-Censits, R B Cohen, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 25, 2000
Gemcitabine for relapsed or resistant lymphomaD G Savage, S A Rule, M Tighe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Phase I trial of docetaxel with estramustine in androgen-independent prostate cancerD P Petrylak, R B Macarthur, J O'Connor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 1998
Phase I trial of sequential high-dose chemotherapy with escalating dose paclitaxel, melphalan, and cyclophosphamide, thiotepa, and carboplatin with peripheral blood progenitor support in women with responding metastatic breast cancerL T Vahdat, K Papadopoulos, C Balmaceda, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 27, 2016
Efficacy of the nanoparticle-drug conjugate CRLX101 in combination with bevacizumab in metastatic renal cell carcinoma: results of an investigator-initiated phase I-IIa clinical trialS M Keefe, J Hoffman-Censits, R B Cohen, et al.
Pageof 2